Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2007-11-14
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00160225
- Locations
- 🇮🇹
Site 1, Ranica, Italy
Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-08-15
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 1251
- Registration Number
- NCT00160342
- Locations
- 🇺🇸
Site 42, Virginia Beach, Virginia, United States
🇺🇸Site 14, Waterbury, Connecticut, United States
🇺🇸Site 4, Groton, Connecticut, United States
Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2009-04-01
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 135
- Registration Number
- NCT00145522
- Locations
- 🇮🇹
Site 8, Ancona, Italy
🇮🇹Site 9, Firenze, Italy
🇮🇹Sit 14, Modena, Italy
To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox
- Conditions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00141479
- Locations
- 🇺🇸
Site 1, Wichita, Kansas, United States
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
- Conditions
- Interventions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 133
- Registration Number
- NCT00141557
- Locations
- 🇺🇸
Site 49, Melbourne, Florida, United States
🇺🇸Site 44, Decatur, Georgia, United States
🇺🇸Site 37, Reno, Nevada, United States
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
- Conditions
- Interventions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 28
- Registration Number
- NCT00141544
- Locations
- 🇺🇸
Site 57, Mobile, Alabama, United States
🇺🇸Site 78, Clearwater, Florida, United States
🇺🇸Site 65, Cary, North Carolina, United States
Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
- Conditions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 350
- Registration Number
- NCT00141570
- Locations
- 🇺🇸
Site 41, Medford, Oregon, United States
🇺🇸Site 60, Columbus, Ohio, United States
🇺🇸Site 49, Melbourne, Florida, United States
Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
- Conditions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00141492
- Locations
- 🇺🇸
Site 3, Portland, Oregon, United States
🇺🇸Site 22, Salem, Virginia, United States
🇺🇸Site 24, Jersey City, New Jersey, United States
PK Effects of Bifeprunox & Valproate in Bipolar I
- Conditions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00141505
- Locations
- 🇺🇸
Site 1, Atlanta, Georgia, United States
Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder
- Conditions
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00139919
- Locations
- 🇺🇸
Site 1, Orange, California, United States